<qa>  What is the primary outcome measure?The primary outcome measure is T1-weighted signal intensity, measured: 1 in the retina, optic nerve, and brain at early time points after mangafodipir administration; and 2 in the basal ganglia, cerebral cortex, and whole brain one month following administration. 